Literature DB >> 19651717

Virgibacillus byunsanensis sp. nov., isolated from a marine solar saltern.

Jung-Hoon Yoon1, So-Jung Kang1, Yong-Taek Jung1, Keun Chul Lee1, Hyun Woo Oh1, Tae-Kwang Oh1.   

Abstract

A Gram-variable, motile, endospore-forming and rod-shaped bacterial strain, ISL-24(T), was isolated from a marine solar saltern of the Yellow Sea, Korea, and its taxonomic position was investigated by a polyphasic study. Strain ISL-24(T) grew optimally at pH 7.0-8.0, at 30-37 degrees C and in the presence of 8 % (w/v) NaCl. It contained MK-7 as the predominant menaquinone and anteiso-C(15 : 0) as the predominant fatty acid. The DNA G+C content was 37.6 mol%. A phylogenetic analysis based on 16S rRNA gene sequences showed that strain ISL-24(T) fell within the genus Virgibacillus, clustering with Virgibacillus carmonensis LMG 20964(T) and Virgibacillus necropolis LMG 19488(T), with a bootstrap resampling value of 92.3 %, and exhibiting 97.3 and 97.4 % 16S rRNA gene sequence similarity, respectively, to these strains. Strain ISL-24(T) exhibited 94.8-96.8 % 16S rRNA gene sequence similarity to the type strains of the other Virgibacillus species. Mean DNA-DNA relatedness values between strain ISL-24(T) and V. carmonensis DSM 14868(T) and V. necropolis DSM 14866(T) were 11 and 19 %, respectively. Differential phenotypic properties of strain ISL-24(T), together with the phylogenetic and genetic distinctiveness, revealed that this strain is different from recognized Virgibacillus species. On the basis of phenotypic, phylogenetic and genetic data, strain ISL-24(T) represents a novel species of the genus Virgibacillus, for which the name Virgibacillus byunsanensis sp. nov. is proposed. The type strain is ISL-24(T) (=KCTC 13259(T) =CCUG 56754(T)).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19651717     DOI: 10.1099/ijs.0.009837-0

Source DB:  PubMed          Journal:  Int J Syst Evol Microbiol        ISSN: 1466-5026            Impact factor:   2.747


  6 in total

1.  Statistical Optimization of the Production of NaCl-Tolerant Proteases by a Moderate Halophile, Virgibacillus sp. SK37.

Authors:  Sornchai Sinsuwan; Anuvat Jangchud; Sureelak Rodtong; Sittirak Roytrakul; Jirawat Yongsawatdigul
Journal:  Food Technol Biotechnol       Date:  2015-06       Impact factor: 3.918

2.  Virgibacillus natechei sp. nov., a moderately halophilic bacterium isolated from sediment of a saline lake in southwest of Algeria.

Authors:  Meriam Amziane; Farida Metiaz; Amel Darenfed-Bouanane; Zahia Djenane; Okba Selama; Ahmed Abderrahmani; Jean-Luc Cayol; Marie-Laure Fardeau
Journal:  Curr Microbiol       Date:  2013-01-10       Impact factor: 2.188

3.  Virgibacillus senegalensis sp. nov., a new moderately halophilic bacterium isolated from human gut.

Authors:  E Seck; J Rathored; S Khelaifia; O Croce; C Robert; C Couderc; F Di Pinto; C Sokhna; D Raoult; J-C Lagier
Journal:  New Microbes New Infect       Date:  2015-10-03

4.  Description of 'Bacillus dakarensis' sp. nov., 'Bacillus sinesaloumensis' sp. nov., 'Gracilibacillus timonensis' sp. nov., 'Halobacillus massiliensis' sp. nov., 'Lentibacillus massiliensis' sp. nov., 'Oceanobacillus senegalensis' sp. nov., 'Oceanobacillus timonensis' sp. nov., 'Virgibacillus dakarensis' sp. nov. and 'Virgibacillus marseillensis' sp. nov., nine halophilic new species isolated from human stool.

Authors:  B Senghor; E H Seck; S Khelaifia; H Bassène; C Sokhna; P-E Fournier; D Raoult; J-C Lagier
Journal:  New Microbes New Infect       Date:  2017-02-02

5.  Noncontiguous finished genome sequence and description of Virgibacillus massiliensis sp. nov., a moderately halophilic bacterium isolated from human gut.

Authors:  S Khelaifia; O Croce; J-C Lagier; C Robert; C Couderc; F Di Pinto; B Davoust; F Djossou; D Raoult; P-E Fournier
Journal:  New Microbes New Infect       Date:  2015-10-02

6.  Biodeterioration Risk Threatens the 3100 Year Old Staircase of Hallstatt (Austria): Possible Involvement of Halophilic Microorganisms.

Authors:  Guadalupe Piñar; Dennis Dalnodar; Christian Voitl; Hans Reschreiter; Katja Sterflinger
Journal:  PLoS One       Date:  2016-02-17       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.